UVa Researchers Find a Treatment that Potentially Could Reduce Heart Disease in the Metabolic Syndrome
Heart Disease Treatment
The metabolic syndrome, a dangerous combination of pre-diabetes and heart disease factors that affects up to 25 percent of the population, is a chief culprit in American illness. As part of an effort to eventually treat this debilitating syndrome, researchers at the University of Virginia have studied biological pathways that affect inflammation in blood vessels that could lead to severe heart disease.
Their findings, published in the Aug. 23 issue of the American Journal of Physiology